Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein

Cancer Cell

Volumn 12, Issue 5, 2007, Pages 457-466

  Fazi, Francesco ^a,b   Racanicchi, Serena ^c   Zardo, Giuseppe ^a,b   Starnes, Linda M ^a,b   Mancini, Marco ^a   Travaglini, Lorena ^a,b   Diverio, Daniela ^a   Ammatuna, Emanuele ^d   Cimino, Giuseppe ^a   Lo Coco, Francesco ^d   Grignani, Francesco ^c   Nervi, Clara ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b San Raffaele Biomedical Park Foundation   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CELLCYCLE; DNA

Indexed keywords

AML1 ETO PROTEIN; HYBRID PROTEIN; MICRORNA; MICRORNA 233; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN NB 4; CELL STRAIN SKNO 1; CELL STRAIN U937; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL;

EID: 35748979703     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.09.020     Document Type: Article

References (39)

1. Ambros V. The function of animal miRNAs. Nature 431 (2004) 350-355
2. Bartell D.P. MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 116 (2004) 281-297
3. Baylin S.B., and Ohm J.E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 6 (2006) 107-116
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., and Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann. Intern. Med. 103 (1985) 620-625
5. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
6. Chen C.-Z., Li L., Lodish H.F., and Bartell D.P. MicroRNAs Modulate Hematopoietic Lineage Differentiation. Science 303 (2004) 83-86
7. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 353 (2005) 1768-1771
8. Chen C.Z., and Lodish H.F. MicroRNAs as regulators of mammalian hematopoiesis. Semin. Immunol. 17 (2005) 155-165
9. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., and Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38 (2006) 228-233
10. Cheng L.C., Tavazoie M., and Doetsch F. Stem Cells From Epigenetics to microRNAs. Neuron 46 (2005) 363-367
11. Dalton Jr. W.T., Ahearn M.J., McCredie K.B., Freireich E.J., Stass S.A., and Trujillo J.M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71 (1988) 242-247
12. Drexler H.G., Macleod R.A., and Uphoff C.C. Leukemia cell lines: In vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk. Res. 23 (1999) 207-215
13. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., and Bozzoni I. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPalpha Regulates Human Granulopoiesis. Cell 123 (2005) 819-831
14. Fazi F., Zardo G., Gelmetti V., Travaglini L., Ciolfi A., Di Croce L., Rosa A., Bozzoni I., Grignani F., Lo-Coco F., et al. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109 (2007) 4432-4440
15. Frank R., Zhang J., Uchida H., Meyers S., Hiebert S.W., and Nimer S.D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11 (1995) 2667-2674
16. Fukao T., Fukuda Y., Kiga K., Sharif J., Hino K., Enomoto Y., Kawamura A., Nakamura K., Takeuchi T., and Tanabe M. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129 (2007) 617-631
17. Grewal S.I., and Moazed D. Heterochromatin and epigenetic control of gene expression. Science 301 (2003) 798-802
18. Grignani F., Ferrucci P.F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Peschle C., Nicoletti I., and Pelicci P.G. The acute promyelocytic leukaemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74 (1993) 423-429
19. Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16 (2006) 4-9
20. Hess J.L., and Hug B.A. Fusion-protein truncation provides new insights into leukemogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 16985-16986
21. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet. 33 Suppl (2003) 245-254
22. Jones P.A., and Baylin S.B. The Epigenomics of Cancer. Cell 128 (2007) 683-692
23. Kim V.N., and Nam J.W. Genomics of microRNA. Trends Genet. 22 (2006) 165-173
24. Klose R.J., and Bird A.P. Genomic DNA methylation: The mark and its mediators. Trends Biochem. Sci. 31 (2006) 89-97
25. Linggi B., Muller-Tidow C., van de Locht L., Hu M., Nip J., Serve H., Berdel W.E., van der Reijden B., Quelle D.E., Rowley J.D., et al. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat. Med. 8 (2002) 743-750
26. Liu S., Shen T., Huynh L., Klisovic M.I., Rush L.J., Ford J.L., Yu J., Becknell B., Li Y., Liu C., et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res. 65 (2005) 1277-1284
27. Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M., Sugiyama D., Lary J., Cole J., Dauter Z., Minor W., et al. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9 (2006) 249-260
28. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
29. Nimer S.D., and Moore M.A. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Oncogene 23 (2004) 4249-4254
30. Pabst T., Mueller B.U., Harakawa N., Schoch C., Haferlach T., Behre G., Hiddemann W., Zhang D.E., and Tenen D.G. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat. Med. 7 (2001) 444-451
31. Radomska H.S., Huettner C.S., Zhang P., Cheng T., Scadden D.T., and Tenen D.G. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18 (1998) 4301-4314
32. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., and Jones P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 (2006) 435-443
33. Santoro R., Li J., and Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat. Genet. 32 (2002) 393-396
34. Tenen D.G. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3 (2003) 89-101
35. Zardo G., Tiirikainen M.I., Hong C., Misra A., Feuerstein B.G., Volik S., Collins C.C., Lamborn K.R., Bollen A., Pinkel D., et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32 (2002) 453-458
36. Zhang D.E., Fujioka K., Hetherington C.J., Shapiro L.H., Chen H.M., Look A.T., and Tenen D.G. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14 (1994) 8085-8095
37. Zhang X., Yazaki J., Sundaresan A., Cokus S., Chan S.W., Chen H., Henderson I.R., Shinn P., Pellegrini M., Jacobsen S.E., and Ecker J.R. Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 126 (2006) 1189-1201
38. Zhao Y., Samal E., and Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005) 214-220
39. Zhou X., Ruan J., Wang G., and Zhang W. Characterization and Identification of MicroRNA Core Promoters in Four Model Species. PLoS Comput. Biol. 3 (2007) e37 10.1371/journal.pcbi.0030037